Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomasini, B. R.
Right arrow Articles by Mosher, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomasini, B. R.
Right arrow Articles by Mosher, D. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea

BR Tomasini and DF Mosher

Department of Medicine, University of Wisconsin, Madison 53706.

A difference in recognition of the adhesive glycoprotein vitronectin (also called S-protein, serum spreading factor, and epibolin) by monoclonal antibody 8E6 (Hayman EG, et al, Proc Natl Acad Sci USA 80:4003, 1983) was investigated using a competitive enzyme- immunosorbent assay and immunoaffinity chromatography. Recognition of vitronectin in serum was approximately 50-fold greater than recognition of vitronectin in plasma. Recognition of vitronectin incubated with heparin, thrombin-antithrombin III complex, or heparin and thrombin- antithrombin III complex together was 2.5-, 7-, or 32-fold greater, respectively, than recognition of vitronectin alone. Thrombin or antithrombin III by itself did not induce the antigenic change. Factor Xa-antithrombin III was less effective than thrombin-antithrombin III in induction of the change. Dextran sulfate and fucoidan were more potent than heparin in induction of the antigenic change, whereas dermatan sulfate, hyaluronic acid, heparan sulfate, chondroitin sulfate, or keratan sulfate were less effective. Immunoblotting analysis of serum and of vitronectin incubated with thrombin and antithrombin III demonstrated the presence of complexes composed of vitronectin and thrombin-antithrombin III that could only be dissociated with reducing agent. N-ethylmaleimide completely blocked the formation of the presumably disulfide-bonded complexes and partially blocked the antigenic change. Both non-disulfide-bonded and disulfide-bonded vitronectin bound to antibody-Sepharose from a mixture of vitronectin and thrombin-antithrombin III. Treatment of vitronectin with 8 mol/L urea resulted in enhanced recognition by the monoclonal antibody. Thus, the 8E6 antibody reacts with an epitope that is preferentially expressed by noncovalently and covalently linked vitronectin/thrombin-antithrombin III complexes and by urea-treated vitronectin. The change in vitronectin induced by thrombin-antithrombin III, therefore, is a physiological correlate of urea treatment and of adsorption of vitronectin onto tissue culture plastic (as is done in cell adhesion assays). The change may be important for expression of vitronectin activity.

Volume 72, Issue 3, pp. 903-912, 09/01/1988
Copyright © 1988 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Sangaletti, E. Di Carlo, S. Gariboldi, S. Miotti, B. Cappetti, M. Parenza, C. Rumio, R. A. Brekken, C. Chiodoni, and M. P. Colombo
Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
Cancer Res., November 1, 2008; 68(21): 9050 - 9059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. H. Minor, C. R. Schar, G. E. Blouse, J. D. Shore, D. A. Lawrence, P. Schuck, and C. B. Peterson
A Mechanism for Assembly of Complexes of Vitronectin and Plasminogen Activator Inhibitor-1 from Sedimentation Velocity Analysis
J. Biol. Chem., August 5, 2005; 280(31): 28711 - 28720.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Okumura, Y. Kamikubo, S. A. Curriden, J. Wang, T. Kiwada, S. Futaki, K. Kitagawa, and D. J. Loskutoff
Kinetic Analysis of the Interaction between Vitronectin and the Urokinase Receptor
J. Biol. Chem., March 8, 2002; 277(11): 9395 - 9404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Podor, S. Campbell, P. Chindemi, D. M. Foulon, D. H. Farrell, P. D. Walton, J. I. Weitz, and C. B. Peterson
Incorporation of Vitronectin into Fibrin Clots. EVIDENCE FOR A BINDING INTERACTION BETWEEN VITRONECTIN AND gamma A/gamma ' FIBRINOGEN
J. Biol. Chem., February 22, 2002; 277(9): 7520 - 7528.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. G. Stupack and D. A. Cheresh
Get a ligand, get a life: integrins, signaling and cell survival
J. Cell Sci., January 10, 2002; 115(19): 3729 - 3738.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. P. Francois, K. T. Preissner, M. Herrmann, R. P. Haugland, P. Vaudaux, D. P. Lew, and K.-H. Krause
Vitronectin Interaction with Glycosaminoglycans. KINETICS, STRUCTURAL DETERMINANTS, AND ROLE IN BINDING TO ENDOTHELIAL CELLS
J. Biol. Chem., December 31, 1999; 274(53): 37611 - 37619.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. P. Fay, A. C. Parker, M. N. Ansari, X. Zheng, and D. Ginsburg
Vitronectin Inhibits the Thrombotic Response to Arterial Injury in Mice
Blood, March 15, 1999; 93(6): 1825 - 1830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. D. Gibson, J. A. Lamerdin, P. Zhuang, K. Baburaj, E. H. Serpersu, and C. B. Peterson
Orientation of Heparin-binding Sites in Native Vitronectin. ANALYSES OF LIGAND BINDING TO THE PRIMARY GLYCOSAMINOGLYCAN-BINDING SITE INDICATE THAT PUTATIVE SECONDARY SITES ARE NOT FUNCTIONAL
J. Biol. Chem., March 5, 1999; 274(10): 6432 - 6442.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Wells and M. A. Blajchman
In Vivo Clearance of Ternary Complexes of Vitronectin-Thrombin-Antithrombin Is Mediated by Hepatic Heparan Sulfate Proteoglycans
J. Biol. Chem., September 4, 1998; 273(36): 23440 - 23447.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Memmo and P McKeown-Longo
The alphavbeta5 integrin functions as an endocytic receptor for vitronectin
J. Cell Sci., January 2, 1998; 111(4): 425 - 433.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and J. W. Smith
The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic
J. Biol. Chem., May 23, 1997; 272(21): 13705 - 13710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and D. Seiffert
The Glycosaminoglycan Binding Site Governs Ligand Binding to the Somatomedin B Domain of Vitronectin
J. Biol. Chem., April 11, 1997; 272(15): 9971 - 9978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Zhuang, A. I. Chen, and C. B. Peterson
Native and Multimeric Vitronectin Exhibit Similar Affinity for Heparin. DIFFERENCES IN HEPARIN BINDING PROPERTIES INDUCED UPON DENATURATION ARE DUE TO SELF-ASSOCIATION INTO A MULTIVALENT FORM
J. Biol. Chem., March 14, 1997; 272(11): 6858 - 6867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and D. J. Loskutoff
Type 1Plasminogen Activator Inhibitor Induces Multimerization of Plasma Vitronectin. A SUGGESTED MECHANISM FOR THE GENERATION OF THE TISSUE FORM OF VITRONECTIN IN VIVO
J. Biol. Chem., November 22, 1996; 271(47): 29644 - 29651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Zhuang, M. N. Blackburn, and C. B. Peterson
Characterization of the Denaturation and Renaturation of Human Plasma Vitronectin. I. BIOPHYSICAL CHARACTERIZATION OF PROTEIN UNFOLDING AND MULTIMERIZATION
J. Biol. Chem., June 14, 1996; 271(24): 14323 - 14332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Zhuang, H. Li, J. G. Williams, N. V. Wagner, D. Seiffert, and C. B. Peterson
Characterization of the Denaturation and Renaturation of Human Plasma Vitronectin. II. INVESTIGATION INTO THE MECHANISM OF FORMATION OF MULTIMERS
J. Biol. Chem., June 14, 1996; 271(24): 14333 - 14343.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. S. Panetti, S. A. Wilcox, C. Horzempa, and P. J. McKeown-Longo
alpha(v)beta(5)Integrin Receptor-mediated Endocytosis of Vitronectin Is Protein Kinase C-dependent
J. Biol. Chem., August 4, 1995; 270(31): 18593 - 18597.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Ribeiro, S Schultz-Cherry, and J. Murphy-Ullrich
Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells
J. Cell Sci., January 4, 1995; 108(4): 1553 - 1561.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
P. Underwood, J. Steele, and B. Dalton
Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies
J. Cell Sci., January 3, 1993; 104(3): 793 - 803.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Podor, S. G. Shaughnessy, M. N. Blackburn, and C. B. Peterson
New Insights into the Size and Stoichiometry of the Plasminogen Activator Inhibitor Type-1{middle dot}Vitronectin Complex
J. Biol. Chem., August 11, 2000; 275(33): 25402 - 25410.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1988 by American Society of Hematology         Online ISSN: 1528-0020